Pd28-01 Still Dry! Longevity of Deflux Urethral Bulking Injections for Urinary Stress Incontinence

Hobbs, Catherine; Foley, Steve

doi:10.1016/j.juro.2015.02.1898

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the formation of pseudocysts in three patients is mentioned (2.1%), the paper does not describe the timing of these or any other complications. 11 Serati et al (first published September 2018) studied the effectiveness of Macroplastique with a minimum follow-up of 3 years. With a median follow of 85 females for 58 months, this study shows that long-term data on bulking agents are limited.…”

Section: Bulking Agentsmentioning

confidence: 99%

See 1 more Smart Citation

Long-term complications of bulking agents in the treatment of stress urinary incontinence: Results of a national survey

Patel

Lazarowicz

Hamm

2022

Journal of Clinical Urology

View full text Add to dashboard Cite

Introduction and Objectives: Bulking agents have been used for decades as an alternative treatment for patients with stress urinary incontinence who are not appropriate for surgery. Despite this their long-term complications are poorly documented and can be misdiagnosed. This paper presents a literature review and the results of a national survey of members of the Section of Female, Neurological and Urodynamic Urology (FNUU) of the British Association of Urological Surgeons (BAUS) identifying the common long-term complications of widely used bulking agents in clinical practice. Methods: Following a comprehensive literature review an electronic survey was sent to members of the BAUS Section of FNUU. Data included hospital trust, use of urethral bulking agents (including type), the approximate number of procedures performed and whether any long-term complications had been observed and managed in their practice. Long-term complications were defined as those arising more than 12 months after treatment. Results: The literature review revealed multiple case reports of complications secondary to bulking agent injection but no high-level evidence regarding frequency or severity. The survey revealed complications including granulomas, erosions, abscesses and misdiagnoses of urethral diverticula and calculi formation. 88% of urologists who responded to the survey had performed a urethral bulking agent injection and 51% of urologists had observed or treated a long-term complication, some many decades after injection. Conclusion: Patients should be made aware of possible long-term complications of what appears to be a minimally invasive procedure in order for them to make an informed choice about treatment options. Level of evidence: Not applicable

show abstract

Section: Bulking Agentsmentioning

confidence: 99%

“…While the formation of pseudocysts in three patients is mentioned (2.1%), the paper does not describe the timing of these or any other complications. 11…”

Section: Introductionmentioning

confidence: 99%